glp 1 agonist tirzepatide Effects of tirzepatide, a dual GIP and GLP-1 receptor agonist, on blood pressure, cardiac function, and sympathetic nervous system in stroke-prone spontaneously hypertensive rats GLP-1 receptor agonists | How

The FDA is in a public comment period - closing June 29, 2026 - on a proposal to formally exclude semaglutide and tirzepatide from the 503B Bulk Drug Substances List, a move that would permanently close large-scale compounding pathways for these active ingredients even in a future shortage

Consistency matters more than timing pick a clock-time you'll actually keep (morning coffee, post-workout, before bed) and stick with it

For the overall group, including those who may have missed doses, the reduction was 18.7% with the high dose, 15.6% with the low dose, and 3.9% with placebo

Learn more about tracking tirzepatide injections or see our Mounjaro progress tracking guide